Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgain AMS on Instagram

Features

  • Safety of vaginal oestrogens in women with breast cancer
    Following their debate at the AMS Congress this year Dr Belinda Kiely and A/Prof Rhea Liang summarise their approach to vaginal oestrogens for women with early breast cancer. Dr Belinda Kiely is a medical oncologist at Campbelltown and Concord Hospitals in Sydney A/Prof Rhea Liang is a breast and ... Read more..
  • eChanges November 2022
    Inside this issue AMS News President's Report Safety of vaginal oestrogens in women with breast cancere New AMS factsheet: Menopause in the workplace New telehealth category for Find an AMS Doctor AMS advocacy assists to keep menopausal hormone therapy on the PBS AMS Member Pro... Read more..
  • Menopause and the workplace
    MAIN POINTS Addressing menopause in the workplace can benefit both the organisation and employees with menopausal symptoms affecting their work Collaborating with employees and including menopausal health in policies can improve an inclusive organisational culture and avoid discrimination agains... Read more..
  • Tibolone
    By Dr Ashley Makepeace The AMS information sheet on ‘Tibolone as a menopausal therapy’ is, regularly, one of the top three most searched information sheets. This is likely due to it being seen as a therapy considered to have the additional benefit with regards to sexual function, and perhaps, due t... Read more..
  • Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: recommendation statement of the US Preventive Services Task Force
    24 October 2022 Summary The US Preventive Services Task Force (USPSTF) published a recommendation on statin use for primary prevention in 2016 [1]. Now the task force has commissioned a new review of the evidence on the benefits and harms of statins as the basis for an update of the 2016 guideline... Read more..
  • Cow's milk intake and risk of coronary heart disease in Korean postmenopausal women
    17 October 2022 Summary Numerous publications have reported conflicting results on the association between cow's milk intake and coronary heart disease (CHD). However, studies involving postmenopausal women are very limited. Recently, Ha et al. [1] reported the results of a study that aimed to ide... Read more..
  • Bisphosphonate treatment and drug holiday
    10 October 2022 Summary Hayes et al. [1] recently reported a study that aimed at examining the comparative risks of drug holidays after long-term (≥3 years, 80% adherence) oral bisphosphonate treatment. This was a population-based cohort study that used province-wide health care administrative dat... Read more..
  • eChanges October 2022
    Inside this issue AMS News President's Report Tibolone AMS membership fees in 2023 Free registrations to GPCE Melbourne 11-13 November 2022 Educational Slides Make Menopause Matter News from Around the World Bisphosphonate treatment and drug holiday Cow's milk intake... Read more..
  • Climacteric E-alert - Vol 25 Iss 5 Oct 22
    Issue Highlights for Month YearVolume 25, Number 5 Welcome to Issue 5 of Climacteric for 2022. This issue contains a broad range of reviews and original work which I commend to you. Please note that the review by J. M. Soares et al. and the review by X. Ruan and A. O. Mueck are both available on Fr... Read more..
  • Climacteric E-alert - Vol 25 Iss 4 Aug 22
    Issue Highlights for Month YearVolume 25, Number 1  Welcome to Issue 4 of Climacteric for 2022. This issue contains a broad range of reviews and original work which I commend to you. Please also read our editorials and commentary on three diverse yet important topics. Rod Baber, Editor-in-Chi... Read more..
  • World Menopause Day 2022
    World Menopause Day is held every year on the 18th October. The purpose of the day is to raise awareness of the menopause and the support options available for improving health and wellbeing. We encourage professionals and women to participate in this global awareness raising campaign by prin... Read more..
  • eChanges September 2022
    Inside this issue AMS News President's Report 25th Annual Australasian Menopause Society Congress – Make Menopause Matter Micronised progesterone (Utrogestan®) to be unrestricted and fully funded in New Zealand Free registrations to GPCE Melbourne 11-13 November 2022 24th AMS Congres... Read more..
  • Our Menopause World September 2022
    President’s Report Dear Friends and Colleagues, I have some exciting news to share with you about CAMS, but before I do, I encourage you to click on this link to view the Scientific Program for the World Congress. With just over a month to go, I strongly encourage you to register here if you haven... Read more..
  • Abnormal Uterine Bleeding in Perimenopausal and Postmenopausal Women
    ModeratorProf Wendy Wolfman SpeakersProf Steven GoldsteinAppropriate evaluation of abnormal uterine bleeding in peri and postmenopausal bleedingProf Scott ChudnoffMedical management of bleeding in peri and postmenopausal patients  Read more..
  • eChanges August 2022
    Inside this issue AMS News President's Report AMS Annual Report 2022 A pregnancy spectrum: A postmenopausal patient with two pregnancies by ovum donation. Updated Information Sheet: AMS guide to MHT/HRT equivalent doses – Australia only Therapeutic Goods Administration Statutory Advisory C... Read more..
  • Aspirin for Primary Prevention of Cardiovascular Disease in Women
    Aspirin for secondary prevention of cardiovascular disease (CVD) is well established for both men and women; however, the benefit of aspirin use in primary prevention of CVD for women has become more controversial. Findings from three aspirin trials have reexamined the benefits of aspirin for primar... Read more..
  • Common Urinary Issues in Midlife Women
    Dr Amanda L. Clark, an obstetrician-gynecologist and a specialist in urogynecology and menopause in Portland, Oregon. Dr Amanda Clark discusses common midlife urinary and bladder issues and how they can affect a woman’s quality of life Read more..
  • Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia:
    a prospective cohort sub study of the Aspree trial. 8 August 2022 Summary Blood testosterone concentrations in women decline during the reproductive years and reach a nadir in the 7th decade after which concentrations increase and are restored to those of reproductive age women in the 8th decade.... Read more..
  • Low sexual function is associated with menopausal status in mid-aged women with HIV infection
    15 August 2022 Summary Recently, Mezones-Holguin et al. [1] reported the results of a study aimed at evaluating the association between menopausal status and female sexual function among mid-aged women with human immunodeficiency virus (HIV) infection. This was a cross-sectional study performed on... Read more..
  • The effects of exercise on vasomotor symptoms in menopausal women:
    a systematic review and meta-analysis 22 August 2022 Summary Liu et al. [1] recently reported a systematic review and meta-analysis that evaluated the potential of structured exercise to alleviate the subjective frequency and severity of vasomotor symptoms (VMS). For this, the authors searched fo... Read more..

Print Email

Search

Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgainAMS on Instagram